Sequential integration of pre-discharge lung ultrasound and the MEESSI-AHF score for safe emergency department discharge in decompensated heart failure: a prospective multicentre cohort study
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background Early revisit or readmission is common after direct emergency department (ED) discharge for decompensated heart failure (DHF, previously termed acute heart failure). We evaluated whether pre-discharge lung ultrasound, quantified as the number of lung fields with B-lines (NLFB-L), improves 30-day risk stratification, alone or integrated with the Multiple Estimation of Risk based on the Emergency department Spanish Score in patients with Acute Heart Failure (MEESSI-AHF). Methods Prospective multicentre cohort study of 96 adults with DHF discharged directly from the EDs of four Spanish tertiary hospitals between November 2023 and January 2026. The primary outcome was heart failure-related ED revisit or hospital readmission within 30 days. Associations were assessed with logistic regression (two-variable models), discrimination with the area under the receiver operating characteristic curve (AUC) compared by the DeLong test, and the optimal NLFB-L threshold with the Youden index. A sequential strategy stratified risk by pre-discharge congestion (NLFB-L < 5 vs ≥ 5), refined by baseline MEESSI-AHF category (low vs non-low). Results The primary outcome occurred in 26 patients (27.1%). NLFB-L was independently associated with the outcome after adjustment for natriuretic peptide levels (adjusted odds ratio 1.51 per additional lung field; 95% confidence interval (CI) 1.21–1.90; p < 0.001). NLFB-L discriminated better than the MEESSI-AHF score (AUC 0.849 vs 0.670; DeLong p = 0.0037), whereas combining both did not improve discrimination (AUC 0.853; p = 0.953). The optimal threshold was NLFB-L ≥ 5 (69.2% sensitivity, 82.9% specificity, 87.9% negative predictive value). NLFB-L < 5 carried a 12.1% event rate; among patients with NLFB-L ≥ 5, event rates were 35.7% with low-risk and 81.3% with non-low-risk MEESSI-AHF (odds ratio 31.42 versus NLFB-L < 5, 95% CI 7.32–134.85; p < 0.001). Conclusions Pre-discharge NLFB-L strongly predicted 30-day heart failure-related revisit or readmission. The added value of the MEESSI-AHF score emerged with sequential integration: a non-low MEESSI-AHF category refined prognosis only in patients with persistent congestion; when both are present, direct ED discharge should be reconsidered. Trial registration: Not applicable (observational study, not registered).
Source: Research Square
Institutions: Hospital Universitario Infanta Cristina, Hospital Universitario La Paz, Hospital Universitari i Politècnic La Fe, Hospital Universitario Fundación Alcorcón, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, University of Alicante, Hospital General Universitario de Alicante Doctor Balmis
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7235159350
